WebLutetium (177 Lu) oxodotreotide or 177 Lu DOTA-TATE, trade name Lutathera, is a chelated complex of a radioisotope of the element lutetium with DOTA-TATE, used in … WebMar 6, 2024 · Lutathera 370 MBq/mL solution for infusion - Summary of Product Characteristics (SmPC) - (emc) Lutathera 370 MBq/mL solution for infusion Active Ingredient: lutetium (177Lu) oxodotreotide Company: Advanced Accelerator Applications See contact details ATC code: V10XX04 About Medicine Prescription only medicine
Launch of Therapeutic Radiopharmaceutical Product, Lutathera
WebLutathera is a radioactive targeted therapy and a type of peptide receptor radionuclide therapy, or PRRT. It is a prescription treatment for adults with GEP-NETs, which are tumors of the neuroendocrine cells in the stomach, gut (foregut, midgut, or hindgut), or pancreas that sometimes make hormones, causing symptoms such as flushing (temporary ... WebFeb 16, 2024 · Dizziness. Change in taste. Anxiety. Hair loss. These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call … dsp stara zagora
Lutathera® (lutetium Lu 177 dotatate) - Magellan Provider
WebJan 28, 2024 · Lutathera is a medication used to treat neuroendocrine tumors. It can help make the tumors grow more slowly or stop them from growing. It can also help manage symptoms caused by the tumors. … WebApr 28, 2024 · Nuclear medicine therapy is a cancer treatment that uses radioactive drugs that bind to cancer cells and destroy them. This therapy is an option for some people with neuroendocrine tumors, prostate cancer, meningiomas, thyroid cancer and lymphoma. It has proved to be successful in easing symptoms, improving quality of life and extending life. WebSep 9, 2024 · Updated PFS data showed 30 events in the Lutathera arm compared with 78 events for the patients treated with octreotide (HR, 0.21; 95% CI, 0.14-0.33; P <.0001). razer 2019